Back

Optum Health Education

  • Antibodies, Bispecific
  • Immunotherapy, Adoptive
  • Multiple Myeloma
  • Neoplasm, Residual

Multiple Myeloma: Navigating Staging, Diagnosis, and Cutting-Edge Treatments

This session will provide an in-depth exploration of current clinical practices and recent advancements in the treatment of multiple myeloma (MM). Participants will learn about the staging and diagnostic processes for MM, including the use of the Revised International Staging System (RISS) and various diagnostic tests. Standard therapies, immunotherapy and CAR T-cell therapy will be discussed, along with new drug approvals, combination therapies, the use of minimal residual disease (MRD) monitoring, as well as emerging therapies such as bispecific antibodies and gene editing.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 creditPsychologyUp to 1 creditSocial WorkUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • Released
    Jun 16, 2025
  • Last day to claim credit
    Jun 17, 2028 2 years left